Post-Market Surveillance (Art 83-86)

The pms entry refers to the Post-Market Surveillance requirements set out in Articles 83 to 86 of the Medical Device Regulation (EU) 2017/745. It obliges manufacturers to systematically collect and evaluate data on device performance after it is placed on the market, enabling timely detection of safety issues and facilitating corrective actions to protect public health.